Boston Scientific Corp.'s $615 million acquisition of Apollo Endosurgery Inc. announced earlier is complementary to the former's endoscopy franchise, as it leverages its gastroenterologist call point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results